Cost-effectiveness analysis in diagnosis of coronary artery disease: Choice of laboratory markers
Samo za registrovane korisnike
2007
Autori
Bogavac-Stanojević, NatašaPetrova, Guenka
Jelić-Ivanović, Zorana
Memon, Lidija
Spasić, Slavica
Članak u časopisu (Objavljena verzija)
Metapodaci
Prikaz svih podataka o dokumentuApstrakt
Objectives: The aim of our study was to determine the cost-effectiveness of coronary artery disease (CAD) diagnostic parameters in a clinical laboratory setting. Design and methods: The effectiveness of apolipoproteins, lipoproteins and high sensitivity C-reactive protein (hs-CRP) supplementary to Framingham scoring data within a CAD risk assessment procedure was established in 221 CAD patients and 289 controls. The total costs of diagnostic procedures were calculated and incremental cost-effectiveness analysis was applied. Results: A diagnostic strategy employing Framingham calculation followed by apolipoprotein A-I (apoA-I) had the lowest cost per additional successfully diagnosed patient than the same strategy followed by hs-CRP in the low (2.63 vs. 24.47 euros) and intermediate-risk groups (2.96 vs. 122.85 euros). in the high-risk group the diagnostic strategy employing apoA-I saved 9.14 euros in comparison to the strategy employing hs-CRP. Conclusion: Cost-effectiveness analysis o...f different diagnostic markers results in improved identification of at-risk patients at a lower health cost for society.
Ključne reči:
cost-effectiveness / coronary artery disease / lipids / lipoproteins / Apolipoproteins / hs-CRPIzvor:
Clinical Biochemistry, 2007, 40, 16-17, 1180-1187Izdavač:
- Pergamon-Elsevier Science Ltd, Oxford
Finansiranje / projekti:
- Ispitivanje biohemijskih i genetičkih faktora rizika kao uzročnika i markera ateroskleroze i drugih oboljenja: analitički i klinički aspekti (RS-MESTD-MPN2006-2010-145036)
DOI: 10.1016/j.clinbiochem.2007.07.004
ISSN: 0009-9120
PubMed: 17869234
WoS: 000250605200002
Scopus: 2-s2.0-35248865222
Institucija/grupa
PharmacyTY - JOUR AU - Bogavac-Stanojević, Nataša AU - Petrova, Guenka AU - Jelić-Ivanović, Zorana AU - Memon, Lidija AU - Spasić, Slavica PY - 2007 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/903 AB - Objectives: The aim of our study was to determine the cost-effectiveness of coronary artery disease (CAD) diagnostic parameters in a clinical laboratory setting. Design and methods: The effectiveness of apolipoproteins, lipoproteins and high sensitivity C-reactive protein (hs-CRP) supplementary to Framingham scoring data within a CAD risk assessment procedure was established in 221 CAD patients and 289 controls. The total costs of diagnostic procedures were calculated and incremental cost-effectiveness analysis was applied. Results: A diagnostic strategy employing Framingham calculation followed by apolipoprotein A-I (apoA-I) had the lowest cost per additional successfully diagnosed patient than the same strategy followed by hs-CRP in the low (2.63 vs. 24.47 euros) and intermediate-risk groups (2.96 vs. 122.85 euros). in the high-risk group the diagnostic strategy employing apoA-I saved 9.14 euros in comparison to the strategy employing hs-CRP. Conclusion: Cost-effectiveness analysis of different diagnostic markers results in improved identification of at-risk patients at a lower health cost for society. PB - Pergamon-Elsevier Science Ltd, Oxford T2 - Clinical Biochemistry T1 - Cost-effectiveness analysis in diagnosis of coronary artery disease: Choice of laboratory markers VL - 40 IS - 16-17 SP - 1180 EP - 1187 DO - 10.1016/j.clinbiochem.2007.07.004 ER -
@article{ author = "Bogavac-Stanojević, Nataša and Petrova, Guenka and Jelić-Ivanović, Zorana and Memon, Lidija and Spasić, Slavica", year = "2007", abstract = "Objectives: The aim of our study was to determine the cost-effectiveness of coronary artery disease (CAD) diagnostic parameters in a clinical laboratory setting. Design and methods: The effectiveness of apolipoproteins, lipoproteins and high sensitivity C-reactive protein (hs-CRP) supplementary to Framingham scoring data within a CAD risk assessment procedure was established in 221 CAD patients and 289 controls. The total costs of diagnostic procedures were calculated and incremental cost-effectiveness analysis was applied. Results: A diagnostic strategy employing Framingham calculation followed by apolipoprotein A-I (apoA-I) had the lowest cost per additional successfully diagnosed patient than the same strategy followed by hs-CRP in the low (2.63 vs. 24.47 euros) and intermediate-risk groups (2.96 vs. 122.85 euros). in the high-risk group the diagnostic strategy employing apoA-I saved 9.14 euros in comparison to the strategy employing hs-CRP. Conclusion: Cost-effectiveness analysis of different diagnostic markers results in improved identification of at-risk patients at a lower health cost for society.", publisher = "Pergamon-Elsevier Science Ltd, Oxford", journal = "Clinical Biochemistry", title = "Cost-effectiveness analysis in diagnosis of coronary artery disease: Choice of laboratory markers", volume = "40", number = "16-17", pages = "1180-1187", doi = "10.1016/j.clinbiochem.2007.07.004" }
Bogavac-Stanojević, N., Petrova, G., Jelić-Ivanović, Z., Memon, L.,& Spasić, S.. (2007). Cost-effectiveness analysis in diagnosis of coronary artery disease: Choice of laboratory markers. in Clinical Biochemistry Pergamon-Elsevier Science Ltd, Oxford., 40(16-17), 1180-1187. https://doi.org/10.1016/j.clinbiochem.2007.07.004
Bogavac-Stanojević N, Petrova G, Jelić-Ivanović Z, Memon L, Spasić S. Cost-effectiveness analysis in diagnosis of coronary artery disease: Choice of laboratory markers. in Clinical Biochemistry. 2007;40(16-17):1180-1187. doi:10.1016/j.clinbiochem.2007.07.004 .
Bogavac-Stanojević, Nataša, Petrova, Guenka, Jelić-Ivanović, Zorana, Memon, Lidija, Spasić, Slavica, "Cost-effectiveness analysis in diagnosis of coronary artery disease: Choice of laboratory markers" in Clinical Biochemistry, 40, no. 16-17 (2007):1180-1187, https://doi.org/10.1016/j.clinbiochem.2007.07.004 . .